Yu, Xin
National Institutes of Health · National Cancer Institute · Center for Cancer Research
8 papers on CoChatORCID 0000-0002-8718-0715
Most cited papers
- Verified
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature
Lymphoma Diagnosis and TreatmentBreast Cancer Treatment Studies
Cited by 9,925
- Verified
Genetics and pathogenesis of diffuse large B-cell lymphoma
Schmitz, R., Wright, G. W., Huang, D. W., Johnson, C. A., Phelan, J. D., Wang, J. Q., Roulland, S., Kasbekar, M., Young, R. M., Shaffer, A. L., et al. (2018) · New England Journal of Medicine
Lymphoma Diagnosis and TreatmentCNS Lymphoma Diagnosis and Treatment
Cited by 2,241
- Verified
IRF4 addiction in multiple myeloma
Shaffer, A. L., Emre, N. C. T., Lamy, L., Ngo, V. N., Wright, G., Xiao, W., Powell, J., Dave, S., Yu, X., Zhao, H., et al. (2008) · Nature
Multiple Myeloma Research and TreatmentsLymphoma Diagnosis and Treatment
Cited by 730
- Verified
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
Richardson, P. G., Oriol, A., Beksac, M., Liberati, A. M., Galli, M., Schjesvold, F., Lindsay, J., Weisel, K., White, D., Facon, T., et al. (2019) · The Lancet Oncology
Multiple Myeloma Research and TreatmentsBone health and treatments
Cited by 386
- Verified
Direct Repression of prdm1 by Bcl-6 Inhibits Plasmacytic Differentiation
Tunyaplin, C., Shaffer, A. L., Angelin-Duclos, C. D., Yu, X., Staudt, L. M., & Calame, K. L. (2004) · The Journal of Immunology
T-cell and B-cell ImmunologyGenomics and Chromatin Dynamics
Cited by 376
- Verified
Oncogenic RAS commandeers amino acid sensing machinery to aberrantly activate mTORC1 in multiple myeloma
Yang, Y., Bolomsky, A., Oellerich, T., Chen, P., Ceribelli, M., Häupl, B., Wright, G. W., Phelan, J. D., Huang, D. W., Lord, J. W., et al. (2022) · Nature Communications
PI3K/AKT/mTOR signaling in cancerMultiple Myeloma Research and Treatments
Cited by 29
- Verified
Three-month subchronic intramuscular toxicity study of rotigotine-loaded microspheres in Cynomolgus monkeys
Tian, J., Du, G., Ye, L., Yu, X., Zhang, J., Wang, H., Yu, P., Fu, F., Liu, W., Li, Y., et al. (2013) · Food and Chemical Toxicology
Parkinson's Disease Mechanisms and TreatmentsImmunotoxicology and immune responses
Cited by 15
- Verified
Three-month subchronic intramuscular toxicity study of rotigotine-loaded microspheres in SD rats
Ye, L., Guan, X., Tian, J., Zhang, J., Du, G., Yu, X., Yu, P., Cen, X., Liu, W., & Li, Y. (2013) · Food and Chemical Toxicology
Parkinson's Disease Mechanisms and TreatmentsAdvanced Drug Delivery Systems
Cited by 14
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free